Ajay Verma - Nov 11, 2021 Form 4 Insider Report for YUMANITY THERAPEUTICS, INC. (KA)

Role
EVP, Head of R&D
Signature
/s/ Marie Epstein, Attorney-in-Fact
Stock symbol
KA
Transactions as of
Nov 11, 2021
Transactions value $
$0
Form type
4
Date filed
11/15/2021, 07:00 AM
Next filing
Dec 3, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KA Stock Option (Right to Buy) Award $0 +5K $0.00 5K Apr 13, 2021 Common Stock 5K $17.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 13, 2021, the reporting person was granted an option to purchase 20,000 shares of common stock, 5,000 shares of which vested and became exercisable upon certain performance criteria being met on November 11, 2021.